Biogen Inc (NASDAQ:BIIB)
| 283.67 BATS BZX Real-Time Price As of 12:34pm ET |  +0.33 / +0.12%Today’s Change | 219.70 Today|||52-Week Range 374.99 | -4.40% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 283.34 |
| Today’s open | 284.26 |
| Day’s range | 280.61 - 285.65 |
| Volume | 19,924 |
| Average volume (3 months) | 1,447,592 |
| Market cap | $43.3B |
Data as of 12:34pm ET, 10/01/2020
Growth & Valuation
| Earnings growth (last year) | +45.55% |
| Earnings growth (this year) | +3.72% |
| Earnings growth (next 5 years) | +0.37% |
| Revenue growth (last year) | +5.49% |
| P/E ratio | 8.3 |
| Price/Sales | 4.37 |
| Price/Book | 3.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +0.65 | +0.21% |
| MRNAModerna Inc | -1.75 | -2.47% |
| IMMUImmunomedics Inc | +0.23 | +0.27% |
| EXASExact Sciences Corp | +1.69 | +1.66% |
Data as of 12:35pm ET, 10/01/2020
Financials
| Next reporting date | October 21, 2020 |
| EPS forecast (this quarter) | $8.20 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 46.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
